SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Zoracles

A sharp rally in the thinly traded, low-market-cap token has fueled speculation of a potential short squeeze, with traders pointing to outsized futures positioning, rising volume and renewed momentum. Bullish participants cite Zoras creator- and attention-market ecosystem, while skeptics view the move as a temporary pump-and-dump and note its broader sensitivity to Bitcoin and altcoin sentiment.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS is drawing attention as its Phase 3 REGAL AML trial approaches the 80th death event that will trigger final efficacy analysis, with traders focused on the prospect of a major binary catalyst. Bulls point to the prolonged survival timeline and supportive comments from pharmaceutical-industry professionals, while bears debate trial design, dosing changes, censoring, and whether the delay signals control-arm strength or statistical risk.

ARK ETF Trust - ARK Innovation ETF

ARK Innovation ETF

Cathie Woods ARK Invest buying and expanding its SpaceX exposure has become the dominant focus, with traders debating whether the concentrated bet strengthens ARKKs innovation strategy or reflects poor timing and excessive risk. The discussion is broadly split between bullish expectations for space, AI and other high-beta holdings and criticism of ARKKs volatility, rebalancing decisions and long-term underperformance.

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Arcturus Therapeutics Holdings Inc

Modernas reported positive Phase 3 cancer-vaccine result has made ARCT a sympathy trade, drawing attention to Arcturuss self-amplifying mRNA platform and related oncology potential. Bulls are also highlighting upcoming CF and OTC-deficiency milestones and short interest, while skeptics point to mixed ARCT-032 data and caution that the rally may be technically overbought.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Michael Burrys reported increase in his Lululemon position has reinforced a contrarian, value-focused trade ahead of upcoming earnings. Traders remain divided, with bulls citing the stocks depressed valuation, potential tariff refunds and incoming CEO, while bears point to weak consumer demand, competition and broader apparel-sector pressure; the tariff benefit remains speculative.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

A sharp pullback in gold and GLD is being attributed to hawkish messaging from Fed Chair Kevin Warsh, rising rate-hike expectations, a firmer dollar and higher yields. Traders remain divided, with bears citing overbought technicals and further downside risk while longer-term bulls point to Treasury bond-buyback policies, fiscal concerns and geopolitical tensions as supportive for gold.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Progress on the proposed European Lithium merger including an amended floating share-exchange ratio, potential cancellation of existing CRML shares, court proceedings, and expected cash inflowhas driven the dominant discussion. Bullish traders view the deal as reducing dilution and strengthening CRMLs rare-earths and lithium platform, while skeptics remain focused on execution delays, future dilution, and the companys pre-revenue status, with short-squeeze speculation amplifying volatility.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apples CEO transition from Tim Cook to John Ternus and the upcoming September 9 iPhone launchexpected to feature a foldable model and expanded AI capabilitiesare driving attention. Traders are split between expecting a pre-event rally on the new product cycle and warning that the expensive foldable, Apples AI lag, valuation, and a potential sell-the-news reaction could limit upside.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Upcoming earnings are the main catalyst, with traders focused on whether Oracles AI-cloud demand, data-center backlog and new partnerships can offset concerns about heavy capital spending and debt. Bullish participants anticipate a pre-earnings rally and short covering, while skepticsincluding traders citing Michael Burrys short thesisexpect pressure from financing, margin and OpenAI-related risks.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforces strong quarterly results, raised outlook, and expanded Anthropic partnership through Claudeforce have fueled a sharp rally, reinforcing the view that AI can augmentand monetizeenterprise software rather than replace it. Traders are broadly bullish and citing short covering and a broader software rotation, though some warn the move is overextended and expect profit-taking or a pullback.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Should You Buy, Hold or Sell Alto Ingredients Stock Post Q2 Earnings?

ALTO has delivered stronger second-quarter profitability, but export headwinds, rising costs and estimate cuts cloud the near-term outlook.

Gevo (GEVO) Q2 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Can 45Z Tax Credits Become Alto Ingredients' Next Earnings Driver?

ALTO's 45Z tax credits are contributing to earnings as it works to expand eligible production and lower carbon intensity.

NANO Nuclear to Report Q3 Earnings:  Buy, Hold or Sell the Stock?

NNE stock heads into Q3 results with improving loss estimates, key regulatory progress and nuclear logistics wins supporting its outlook.

Gevo, Inc. (GEVO) Reports Q2 Loss, Beats Revenue Estimates

Gevo (GEVO) delivered earnings and revenue surprises of +50.00% and +2.23%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Texas Pacific (TPL) Tops Q2 Earnings and Revenue Estimates

Texas Pacific (TPL) delivered earnings and revenue surprises of +4.21% and +1.26%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

 Bloom Energy Q2 Earnings Beat Estimates on Product Growth, View Up 

BE's second-quarter earnings and revenues rise on product growth and onsite power demand, prompting higher 2026 revenue, profit and EPS guidance.

Could E15 Adoption Unlock Alto Ingredients' Next Growth Phase?

ALTO could gain from broader year-round E15 sales, which may lift ethanol demand as operations improve and 45Z credits support production.

Friday Sector Leaders: Oil & Gas Refining & Marketing, Insurance Brokers

In trading on Friday, oil & gas refining & marketing shares were relative leaders, up on the day by about 1.4%. Leading the group were shares of Equinor, up about 3.8% and shares of Gevo up about 2.8% on the day.

Also showing relative strength are insurance brokers sha...

ALTO Trades at a Discount Despite 344% Rally in a Year: What's Next?

ALTO's strong rally reflects improving profitability, favorable market trends and growth initiatives, while its valuation remains attractive.

• Reported GAAP EPS of -$0.75 down -7600.00% YoY
• Reported revenue of $46.5M up 7.11% YoY
• Gevo expects full year 2026 non-GAAP Adjusted EBITDA to be greater than $60 million, which is more than double the prior target of $30 million, supported by carbon business revenue growth.

Gevo reported a significant net loss of $177 million in the second quarter of 2026, driven by a $176 million non-cash impairment charge and a strategic exit from South Dakota operations.

Gevo raised its 2026 EBITDA outlook to over $60 million, supported by new Canadian market compliance opportunities and increased monetization of Section 45Z tax credits from low-carbon fuel production growth.

Gevo, Inc. is a renewable chemicals and next generation biofuels company, which focuses on the development and commercialization of renewable alternatives to petroleum-based products. It operates through the following segments: Gevo and Gevo Development and Agri-Energy. The Gevo segment focuses on the research and development activities related to the future production of isobutanol, including the development of the firm's proprietary biocatalysts, the production and sale of renewable jet and other fuels, the retrofit process, and the next generation of chemicals and biofuels that will be based on the company's isobutanol technology. The Gevo Development and Agri-Energy segment is currently responsible for the operation of its agri-energy facility and the production of ethanol, isobutanol, and related products. The company was founded by Christopher Michael Ryan, Matthew W. Peters, Peter Meinhold, and Frances Hamilton Arnold on June 9, 2005 and is headquartered in Englewood, CO.

Gevo Inc

Why Is GEVO Stock Sliding 12% Premarket Today?

Equity

Bullish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards a positive week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$1.67
Prev Close	$1.68
Open	$1.69
Dividend Yield	0.00%
50-Day Moving Average	$1.54
Beta	1.33
Avg. Volume	3.39M
PE Ratio	-1.86

52-Week High	$2.97
52-Week Low	$1.37
Market Capitalization	$412.89M
EPS (Annual)	-$0.1446
Price to Book	1.51
Revenue Per Employee	$1.06M

Feed

News

Sentiment

Earnings

Fundamentals

Info